Pulse steroids: How much is enough?
- 1 February 2006
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (2) , 111-113
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Glucocorticoids in the treatment of rheumatic diseases: An update on the mechanisms of actionArthritis & Rheumatism, 2004
- Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosusAnnals of the Rheumatic Diseases, 2001
- Molecular mechanisms of anti‐inflammatory action of glucocorticoidsBioEssays, 1996
- A double blind, placebo controlled trial of intravenous methylprednisolone in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1988
- A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.Annals of the Rheumatic Diseases, 1987
- Central nervous system manifestations after pulse therapy for systemic lupus erythematosusArthritis & Rheumatism, 1983
- Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1982
- Pulse methylprednisolone therapy in diffuse proliferative lupus nephritisThe Journal of Pediatrics, 1982
- The treatment of lupus nephritis by methyl prednisolone pulse therapyPostgraduate Medical Journal, 1978
- BENEFICIAL EFFECTS OF METHYLPREDNISOLONE "PULSE" THERAPY IN DIFFUSE PROLIFERATIVE LUPUS NEPHRITISThe Lancet, 1976